China’s 2025 Negative List for Market Access marks a further step toward liberalization, cutting down the number of restricted industries and easing private investment restrictions in industries such ...

Biocon Biologics Ltd., today announced the Company has secured multiple market access agreements for Yesintek™ ...

Manifest, the first company to successfully bring U.S. private equity real estate on-chain in a scalable and liquid format, ...

Prior to joining EVERSANA MANAGEMENT CONSULTING, Svoboda was a management consultant in the market access practices of companies such as Syneos, ICON, and Guidehouse. She has supported clients ...

In the feature ‘Successfully navigating the complexity of market access across Europe to improve health equity’, originally published in the European Biopharmaceutical Review, EVERSANA General ...

THE Department of Trade and Industry (DTI) will expand market access, provide “targeted support” to industries, and attract high-quality investments to ensure inclusive and sustainable ...

Finance minister Nirmala Sitharaman has said the Free Trade Agreement (FTA) that India signed with the United Kingdon on May 6 marked “a new era in bilateral trade”, which would offer wider ...

Biocon Biologics has secured multiple market access agreements for Yesintek (ustekinumab-kfce), its biosimilar to Stelara (ustekinumab). The market access agreements from numerous plans represent over ...

It is capitalizing on its 'lab to market' capabilities to serve millions of patients across 120+ countries by enabling affordable access to high quality biosimilars. The Company is leveraging ...

by 2040 with liberal market access and eased trade restrictions. “These landmark agreements will further deepen our comprehensive strategic partnership, and catalyse trade, investment ...

Moreover, the agreement includes provisions aimed at liberalizing non-tariff measures, such as product standards and technical regulations, which will lower market access costs for SMEs in order ...